⌘K

16:30:42·158d

SECFilingvia Quantisnow

Actuate Therapeutics Inc. filed SEC Form 8-K: Other Events

ByQuantisnow·Wall Street's wire, on your screen.

ACTU· Actuate Therapeutics Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

ACTU
Actuate Therapeutics Inc.
Health Care

Recent analyst ratings

Aug 26UpdateB. Riley Securities$20.00
Apr 22UpdateCraig Hallum$21.00
Mar 17UpdateH.C. Wainwright$20.00

Related

PR15d
Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
SEC23d
SEC Form DEFA14A filed by Actuate Therapeutics Inc.
SEC23d
SEC Form DEF 14A filed by Actuate Therapeutics Inc.
INSIDER27d
SEC Form 4 filed by Schmitt Daniel M
INSIDER27d
SEC Form 4 filed by Mazar Andrew Paul
INSIDER27d
SEC Form 4 filed by Lytle Paul J
SEC34d
SEC Form 10-K filed by Actuate Therapeutics Inc.
NEWS36d
Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers